Information Provided By: 
Fly News Breaks for May 30, 2018
EXAS
May 30, 2018 | 12:59 EDT
BTIG analyst Sean Lavin maintained a Buy rating on Exact Sciences shares and raised his price target to $70 from $60, as he sees the new guidelines released by the American Cancer Society giving a qualified recommendation that adults 45-50 should consider screening either with a high sensitivity test or imaging as a a positive for Exact Sciences and the beginning of screening moving earlier.
News For EXAS From the Last 2 Days
There are no results for your query EXAS
